The debate over whether transgender people should serve in the armed forces has taken a new turn after a thorough academic review contradicted the administration’s public rationale. A paper published in the International Journal of Transgender Health examined 58 empirical studies and concluded that the common claims used to justify the trans military ban—that transgender members are inherently undeployable, damage unit cohesion, or impose outsized healthcare costs—are not supported by the available evidence. This analysis arrives as litigation proceeds over benefits stripped from active-duty members affected by the policy.
Those legal and scientific threads come from the same root: an executive order issued in January 2026 that sought to remove transgender people from military service. The review’s authors looked for consistent, peer-reviewed findings and found none supporting the administration’s core assertions. At the same time, veterans and service members are contesting administrative decisions in court, arguing that promised retirement benefits were unlawfully taken away as their separations were processed.
What the research shows
Costs and medical care
The literature review found that the U.S. military’s annual spending on healthcare for transgender personnel is modest in scale: roughly $5 million per year, with approximately $1 million directed toward gender-affirming care. By contrast, the Department of Defense bears far larger expenses for common conditions affecting a young, active population—such as musculoskeletal injuries, pregnancy and childbirth, obesity-related treatment, and vision care. Prior work, including a 2016 RAND analysis, similarly concluded that trans-related medical costs are a very small fraction of the military’s total healthcare budget, and do not threaten readiness or financial stability.
Deployability and cohesion
Opponents of transgender service often argue that medical procedures or hormonal treatment cycles make trans service members less able to deploy. The review contradicts that claim: studies show many transgender personnel and medical teams coordinate treatment timing around operational needs, so that periods of recovery do not systematically reduce deployability. No consistent empirical link emerged tying transgender status to breakdowns in unit cohesion. Instead, evidence points toward discrimination, harassment, and stigma as the primary drivers of adverse mental health outcomes among transgender service members, while supportive leadership and affirming policies improve wellbeing for both transgender and cisgender troops.
Legal battle over retirement benefits
The administrative response to the executive order created a separate, pressing legal issue. After the president’s directive, the Air Force initially offered qualifying transgender personnel a path to early retirement under Temporary Early Retirement Authority (TERA), which would have preserved lifetime benefits for some who had completed 15–18 years of service. That offer was later withdrawn and replaced with an ultimatum: accept a one-time separation payment with no ongoing benefits, or face administrative separation without pay. The reversal effectively stripped many service members of prorated pensions, access to TRICARE, military housing eligibility, and disability benefits they had planned around.
Seventeen transgender Air Force members responded by filing suit—Logan Ireland et al. v. United States—arguing that the policy change disrupted expectations and destabilized future plans. In a recent filing, the Department of Justice asked the Court of Federal Claims to dismiss the claims of 16 plaintiffs on the basis that they remain in a form of paid leave during separation processing and therefore have not suffered presently due monetary damages. The DOJ framed the dispute as one about future benefits and court jurisdiction, setting up a potentially consequential ruling on whether the Air Force’s reversal was lawful.
Precedents, courtroom signals, and stakes
Courtroom decisions and past research offer context for what may come next. Earlier judicial scrutiny has already undercut parts of the administration’s narrative: a federal judge last February rejected the proposition that respectful pronoun use undermines troop effectiveness, viewing that argument as reflective of personal animus rather than operational evidence. Scholarship, including the RAND report, has likewise found no operational or readiness problems in foreign militaries that have integrated transgender service members successfully.
The immediate outcomes of the ongoing litigation will determine whether affected service members regain promised benefits and whether the government’s approach to policy rollouts survives legal review. Beyond the courtroom, the debate affects unit culture, mental health among service members, and how future personnel policies balance medical needs and operational demands. For policymakers, commanders, and advocates alike, the combined force of empirical research and litigation underscores that any decision about service eligibility should rest on data, not unsubstantiated claims or stigma.